The International Organization for Medical Physics - a driving force for the global development of medical physics.

The International Organization for Medical Physics (IOMP) is the world's largest professional organization in the field of medical physics and has official non-governmental organization status with the World Health Organization (WHO) and the International Atomic Energy Agency (IAEA). IOMP is charged with a mission to advance medical physics practice worldwide by disseminating scientific and technical information, fostering the educational and professional development of medical physics and promoting the highest quality medical services for patients. IOMP's activities are directed towards the promotion of medical physics globally, improving patient care, and contributing to the benefit of healthcare to the society. Major organizational activities include but are not limited to scientific events, international collaborations, dissemination of information, education, training, and research. For nearly 60 years of existence, IOMP turned into a key factor not only in the field of medical physics, but also healthcare, and other related disciplines. IOMP is looking forward to future perspectives in international collaboration and enhancement of the professional skills, all directed towards enhancing patient benefit.

A method to enhance 2D ion chamber array patient specific quality assurance for IMRT.

Gamma index comparison has been established as a method for patient specific quality assurance in IMRT. Detector arrays can replace radiographic film systems to record 2D dose distributions and fulfill quality assurance requirements. These electronic devices present spatial resolution disadvantages with respect to films. This handicap can be partially overcome with a multiple acquisition sequence of adjacent 2D dose distributions. The detector spatial response influence can also be taken into account through the convolution of the calculated dose with the detector spatial response. A methodology that employs both approaches could allow for enhancements of the quality assurance procedure. 35 beams from different step and shoot IMRT plans were delivered on a phantom. 2D dose distributions were recorded with a PTW-729 ion chamber array for individual beams, following the multiple acquisition methodology. 2D dose distributions were also recorded on radiographic films. Measured dose distributions with films and with the PTW-729 array were processed with the software RITv5.2 for Gamma index comparison with calculated doses. Calculated dose was also convolved with the ion chamber 2D response and the Gamma index comparisons with the 2D dose distribution measured with the PTW-729 array was repeated. 3.7 ± 2.7% of points surpassed the accepted Gamma index when using radiographic films compared with calculated dose, with a minimum of 0.67 and a maximum of 13.27. With the PTW-729 multiple acquisition methodology compared with calculated dose, 4.1 ± 1.3% of points surpassed the accepted Gamma index, with a minimum of 1.44 and a maximum of 11.26. With the PTW- multiple acquisition methodology compared with convolved calculated dose, 2.7 ± 1.3% of points surpassed the accepted Gamma index, with a minimum of 0.42 and a maximum of 5.75. The results obtained in this work suggest that the comparison of merged adjacent dose distributions with convolved calculated dose represents an enhancement in the methodology for IMRT patient specific quality assurance with the PTW-729 ion chamber array.

A framework for the implementation of new radiation therapy technologies and treatment techniques in low-income countries.

We present a practical, generic, easy-to-use framework for the implementation of new radiation therapy technologies and treatment techniques in low-income countries. The framework is intended to standardize the implementation process, reduce the effort involved in generating an implementation strategy, and provide improved patient safety by reducing the likelihood that steps are missed during the implementation process. The 10 steps in the framework provide a practical approach to implementation. The steps are, 1) Site and resource assessment, 2) Evaluation of equipment and funding, 3) Establishing timelines, 4) Defining the treatment process, 5) Equipment commissioning, 6) Training and competency assessment, 7) Prospective risk analysis, 8) System testing, 9) External dosimetric audit and incident learning, and 10) Support and follow-up. For each step, practical advice for completing the step is provided, as well as links to helpful supplementary material. An associated checklist is provided that can be used to track progress through the steps in the framework. While the emphasis of this paper is on addressing the needs of low-income countries, the concepts also apply in high-income countries.

A method to enhance spatial resolution of a 2D ion chamber array for quality control of MLC.

This work introduces a new method for verifying MLC leaf positions with enough spatial resolution to replace film-based methods in performing QA tests. It is implemented on a 2D ion chamber array, and it is based on the principle of varying signal response of a volumetric detector to partial irradiation. A PTW 2D-ARRAY seven29 (PTW-729 2D) array was used to assess a Siemens OPTIFOCUS MLC. Partial volume response curves for chambers in the array were obtained by irradiating them with the leaves of the MLC, progressively covering varying portions of the chambers correlated with the leaf positions. The readings from the array's chambers are processed with an in-house program; it generates a reference response that translates readings into leaf positions. This principle allows discriminating errors in pairs of opposing leaves that could combine to cancel their detection with other tools. Patterns of leaf positions, similar to the Bayouth test but with different, purposefully introduced errors, were generated and used to test the effectiveness of the method. The same patterns were exposed on radiographic film and analyzed with the RIT software for validation. For four test patterns with a total of 100 errors of ± 1 mm, ± 2 mm and ± 3 mm, all were correctly determined with the proposed method. The analysis of the same pattern with film using the Bayouth routine in the RIT software resulted in either somewhat low true positives combined with a large fraction of false positives, or a low true positive rate with a low false positive ratio, the results being significantly affected by the threshold selected for the analysis. This method provides an effective, easy to use tool for quantitative MLC QA assessment, with excellent spatial resolution. It can be easily applied to other 2D arrays, as long as they exhibit a partial volume detector response.